AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $420,000 | +22.8% | 25,108 | +6.0% | 0.04% | -2.4% |
| Q1 2020 | $342,000 | -57.4% | 23,690 | -1.1% | 0.04% | -42.3% |
| Q4 2019 | $802,000 | +21.7% | 23,958 | -23.8% | 0.07% | +10.9% |
| Q3 2019 | $659,000 | +43.6% | 31,454 | +42.6% | 0.06% | +39.1% |
| Q2 2019 | $459,000 | +85.8% | 22,057 | +99.4% | 0.05% | +70.4% |
| Q1 2019 | $247,000 | -2.8% | 11,060 | +4.3% | 0.03% | -15.6% |
| Q4 2018 | $254,000 | -3.4% | 10,603 | +10.1% | 0.03% | +6.7% |
| Q3 2018 | $263,000 | -2.2% | 9,633 | -3.7% | 0.03% | -9.1% |
| Q2 2018 | $269,000 | -7.9% | 9,998 | +9.0% | 0.03% | -13.2% |
| Q1 2018 | $292,000 | – | 9,174 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 1,240,000 | $25,966,000 | 57.34% |
| Foresite Capital Management II, LLC | 2,605,499 | $54,559,000 | 11.53% |
| Foresite Capital Management III, LLC | 611,893 | $12,813,000 | 4.89% |
| Palo Alto Investors LP | 3,471,740 | $72,698,000 | 4.84% |
| SANDERS MORRIS HARRIS LLC | 486,906 | $10,196,000 | 2.47% |
| Eventide Asset Management | 3,084,000 | $64,579,000 | 2.13% |
| Sofinnova Investments, Inc. | 346,770 | $7,261,000 | 0.66% |
| EMERALD ADVISERS, LLC | 610,511 | $12,784,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 752,358 | $15,754,000 | 0.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 587,464 | $12,301,000 | 0.54% |